Per a news item from Novagali Pharma on Tuesday, this is expected to enter Phase III clinical trials in the US in the second quarter of 2008.
In our clinical trial roster on The Dry Eye Zone I previously had this down as already being in Phase III (based on an April press release) but I've relegated it to Phase II till the Phase IIIs actually start.
No comments:
Post a Comment